Bayer and Onyx Launch Educational Program to Raise Awareness About Liver Cancer and Its Ri... (ancer. About Liver Cancer Liver c...)

Bayer and Onyx Launch Educational Program to Raise Awareness About Liver Cancer and Its Risk Factors

Date:10/28/2008

ancer."

About Liver Cancer

Liver cancer is the sixth most common cancer in the world and the third leading cause of cancer-related deaths globally. More than 600,000 cases of liver cancer are diagnosed worldwide each year (more than 400,000 in China, South Korea, Japan and Taiwan, 54,000 in the European Union, and 15,000 in the United States) and the incidence is increasing. In 2002, approximately 600,000 people died of liver cancer including approximately 370,000 in China, South Korea and Japan, 57,000 in the European Union, and 13,000 in the United States.(3,4)

Liver cancer often results from certain liver-related illnesses such as hepatitis B, hepatitis C, alcohol abuse, fatty liver disease, and exposure to chemicals. Additionally, HIV patients infected with hepatitis C have approximately a five times greater risk of developing liver cancer than patients infected with HIV alone.(5)

Treatment options for liver cancer patients are limited and depend on the stage of the malignant disease, underlying liver function and the patient's overall condition.(6) Five standard treatments are used to treat liver cancer: surgery, radiation therapy, chemotherapy (e.g., transarterial chemoembolization), percutaneous ethanol injection and targeted therapy.(7)

About the Survey

The GfK Roper Public Affairs & Media survey was conducted in July and August 2008 in the United States, United Kingdom, Italy, Spain, Mexico, China and Japan via telephone interviews using a computer assisted telephone interviewing program. All interviews were among national samples of adults (18+) who were randomly selected to take the survey using a random digit dial (RDD) or equivalent random selection method. Approximately 1,000 interviews were completed in each country.

Completed interviews were weighted to match national norms and to help ensure a reliable and accurate representation of the public. At the 95 percent confidence level, the margin of error f
'/>"/>

0

GOOD

Page: 1 2 3 4 5 6 7
Related medicine news :

1. Bayer Diabetes Care Partners with Nick Jonas to Encourage Young People to Proactively Manage Their Diabetes
2. Photos: Bayer Names New U.S. CEO
3. Bayer USA Foundation Supports Summer Science Education Programs in Pittsburgh, Raleigh, Houston and Tyler, Texas
4. Barr and Bayer Sign Supply and Licensing Agreements for Launch of Generic Yasmin(R) and Yaz(R) Oral Contraceptives
5. Statement From Bayer(R) Aspirin Regarding the American Medical Associations New Aspirin Policy Resolution
6. Bayer Announces Availability of Reformulated Liquid Leukine(R)
7. ACT Biotech Acquires Clinical and Early Stage Oncology Portfolio Licenses From Bayer Healthcare
8. United Nations Environment Programme and Bayer Corporation Announce North American Winners of International Childrens Painting Competition
9. Bayer/Schering-Plough/Shionogis Avelox Has Advantages Over Levofloxacin in the Treatment of Community-Acquired Pneumonia
10. Bayer HealthCare Pharmaceuticals, Amerinet Extend Contrast Media Agreement
11. Bayer to Receive Two Top National Awards for Its Science Education, Science Literacy Work

Post Your Comments:

Bayer and Onyx Launch Educational Program to Raise Awareness About Liver Cancer and Its Ri...(ancer. About Liver Cancer Liver c...),Health